Ex vivo-generated T cell precursors enhance thymic regeneration and T cell immunity after allogeneic hematopoietic cell transplantation
Jennifer J. Tsai(Memorial Sloan Kettering Cancer Center), Marcel R.M. van den Brink(City Of Hope National Medical Center), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Andri Leó Lemarquis(Reykjavík University), Jennifer Zhang(Bristol-Myers Squibb (Germany)), Anastasia I. Kousa(City Of Hope National Medical Center), Olivier Nègre(Inserm), Ranjita Devi Moirangthem(DSM (France)), Joseph C. Sun(Memorial Sloan Kettering Cancer Center), Tayebeh Soheili(DSM (France)), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Lucia Serrano-Marin(Memorial Sloan Kettering Cancer Center), Teresa Cato(Kettering University), Marina Cavazzana(Université Rennes 2)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k